Below are the most recent publications written about "Aspirin" by people in Profiles.
-
Brett AS. Should Patients Take Aspirin for Primary Cardiovascular Prevention?: Updated Recommendations From the US Preventive Services Task Force. JAMA. 2022 04 26; 327(16):1552-1554.
-
Turan TN, Zaidat OO, Gronseth GS, Chimowitz MI, Culebras A, Furlan AJ, Goldstein LB, Gonzalez NR, Latorre JG, Messé SR, Nguyen TN, Sangha RS, Schneck MJ, Singhal AB, Wechsler LR, Rabinstein AA, Dolan O'Brien M, Silsbee H, Fletcher JJ. Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee. Neurology. 2022 03 22; 98(12):486-498.
-
King RW, Dias AP, MukherJee RD, Genovese EA, Veeraswamy RK, Wooster MD. Staging Endovascular Thoracic and Thoracoabdominal Aortic Aneurysm Repairs and the Risk of Post-operative Spinal Cord Ischemia. Ann Vasc Surg. 2022 Sep; 85:299-304.
-
Gutierrez J, Turan TN, Hoh BL, Chimowitz MI. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2022 04; 21(4):355-368.
-
Gaisina IN, Hushpulian DM, Gaisin AM, Kazakov EH, Ammal Kaidery N, Ahuja M, Poloznikov AA, Gazaryan IG, Thatcher GRJ, Thomas B. Identification of a potent Nrf2 displacement activator among aspirin-containing prodrugs. Neurochem Int. 2021 10; 149:105148.
-
Jones WS, Mulder H, Wruck LM, Pencina MJ, Kripalani S, Muñoz D, Crenshaw DL, Effron MB, Re RN, Gupta K, Anderson RD, Pepine CJ, Handberg EM, Manning BR, Jain SK, Girotra S, Riley D, DeWalt DA, Whittle J, Goldberg YH, Roger VL, Hess R, Benziger CP, Farrehi P, Zhou L, Ford DE, Haynes K, VanWormer JJ, Knowlton KU, Kraschnewski JL, Polonsky TS, Fintel DJ, Ahmad FS, McClay JC, Campbell JR, Bell DS, Fonarow GC, Bradley SM, Paranjape A, Roe MT, Robertson HR, Curtis LH, Sharlow AG, Berdan LG, Hammill BG, Harris DF, Qualls LG, Marquis-Gravel G, Modrow MF, Marcus GM, Carton TW, Nauman E, Waitman LR, Kho AN, Shenkman EA, McTigue KM, Kaushal R, Masoudi FA, Antman EM, Davidson DR, Edgley K, Merritt JG, Brown LS, Zemon DN, McCormick TE, Alikhaani JD, Gregoire KC, Rothman RL, Harrington RA, Hernandez AF. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 05 27; 384(21):1981-1990.
-
Haley SP, Chessman A. Treatment effect of aspirin for primary prevention does not differ according to baseline ASCVD risk. Ann Intern Med. 2020 10 20; 173(8):JC39.
-
Abdul Rahman L, Turan TN, Cotsonis G, Almallouhi E, Holmstedt CA, Chimowitz MI. Dual Antiplatelet Therapy Beyond 90 days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105254.
-
Schlosser RJ. Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches. Int Forum Allergy Rhinol. 2020 09; 10(9):1035-1036.
-
Marquis-Gravel G, Roe MT, Robertson HR, Harrington RA, Pencina MJ, Berdan LG, Hammill BG, Faulkner M, Muñoz D, Fonarow GC, Nallamothu BK, Fintel DJ, Ford DE, Zhou L, Daugherty SE, Nauman E, Kraschnewski J, Ahmad FS, Benziger CP, Haynes K, Merritt JG, Metkus T, Kripalani S, Gupta K, Shah RC, McClay JC, Re RN, Geary C, Lampert BC, Bradley SM, Jain SK, Seifein H, Whittle J, Roger VL, Effron MB, Alvarado G, Goldberg YH, VanWormer JL, Girotra S, Farrehi P, McTigue KM, Rothman R, Hernandez AF, Jones WS. Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. JAMA Cardiol. 2020 05 01; 5(5):598-607.